statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Bitcoin

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Invesco QQQ Trust Series 1

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Cabaletta Bio (NASDAQ:CABA - Free Report) had its price objective lifted by Citigroup from $26.00 to $30.00 in a report published on Thursday morning, Benzinga reports. Citigroup currently has a buy...

Citigroup Boosts Cabaletta Bio (NASDAQ:CABA) Price Target to $30.00

Cabaletta Bio (NASDAQ:CABA - Get Free Report) had its target price raised by stock analysts at Citigroup from $26.00 to $30.00 in a research note issued to investors on Thursday, Benzinga reports...

Cabaletta Bio (NASDAQ:CABA) PT Raised to $30.00

See the rest of the story here.

thefly.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps individual...

Cabaletta Bio price target raised by $4 at Citi, here's why

For the last three days, A.I.dvisor has detected that CABA's AroonDown red line is above 70 while the AroonUp green line is below 30 for three straight days. This move could indicate a strong...

Cabaletta Bio (CABA, $16.83) Aroon Indicator entered a Downtrend on April 01, 2024.

Cabaletta Bio (CABA, $17.04) Aroon Indicator entered a Downtrend on March 28, 2024.

Cabaletta Bio (CABA, $17.14) Aroon Indicator entered a Downtrend on March 27, 2024.

Cabaletta Bio, Inc. (NASDAQ:CABA  Free Report)  William Blair issued their Q1 2024 earnings per share (EPS) estimates for Cabaletta Bio in a note issued to investors on Thursday...

Cabaletta Bio, Inc. to Post Q1 2024 Earnings of ($0.51) Per Share, William Blair Forecasts (NASDAQ:CABA)

Cabaletta Bio (CABA, $16.96) Aroon Indicator entered a Downtrend on March 26, 2024.

Cabaletta Bio (NASDAQ:CABA  Free Report) had its price target hoisted by HC Wainwright from $25.00 to $30.00 in a report released on Friday, Benzinga reports. The firm currently has a buy...

Cabaletta Bio (NASDAQ:CABA) Price Target Raised to $30.00

Cabaletta Bio (NASDAQ:CABA  Free Report) had its target price raised by Wells Fargo  Company from $34.00 to $35.00 in a report issued on Friday, Benzinga reports. The brokerage currently...

Cabaletta Bio (NASDAQ:CABA) Given New $35.00 Price Target at Wells Fargo & Company

Cabaletta Bio, Inc. is a clinical-stage biotechnology company, which engages in the discovery and development of engineered T cell therapies for B cell-mediated autoimmune diseases. Its proprietary technology utilizes chimeric autoantibody receptor to selectively bind and eliminate B cells that produce disease-causing autoantibodies. The company was founded by Michael C. Milone, Steven Nichtberger, and Aimee Payne in April 2017 and is headquartered in Philadelphia, PA.

Volume	817,484.00
52-Wk High	$26.35
52-Wk Low	$9.02

CABA Cabaletta Bio Inc

About

Feed

News

Sentiment

Earnings

Fundamentals